Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: A case-control study
Open Access
- 1 July 1996
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 35 (4) , 751-757
- https://doi.org/10.1016/0360-3016(96)00150-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Local recurrence versus new primary: Clinical analysis of 82 breast relapses and potential applications for genetic fingerprintingInternational Journal of Radiation Oncology*Biology*Physics, 1993
- HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.Journal of Clinical Oncology, 1992
- Significance of ipsilateral breast tumour recurrence after lumpectomyThe Lancet, 1991
- Ten year results of conservative surgery and irradiation for stage I and II breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1991
- c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodesBritish Journal of Cancer, 1991
- Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatmentInternational Journal of Radiation Oncology*Biology*Physics, 1990
- An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapyBritish Journal of Cancer, 1990
- Why are local recurrences after breast-conserving therapy more frequent in younger patients?Journal of Clinical Oncology, 1990
- The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast.Journal of Clinical Oncology, 1990
- Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast CancerNew England Journal of Medicine, 1989